ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) will host an R&D day in New York City on June 25, 2025, at 8:30 AM ET. The event will focus on discussing its neurological and rare diseases pipeline, featuring members of Acadia's management team, R&D organization, key opinion leaders, and members of the caregiver community.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250604630277) on June 05, 2025, and is solely responsible for the information contained therein.